EU to Launch Anti-Dumping Investigation on Chinese PBAT Imports

EU to Open China Dumping Probe into Key Chemical Imports, Sources Say

The European Commission is set to open a new anti-dumping investigation into Chinese imports of polybutylene adipate terephthalate (PBAT), a biodegradable plastic, according to two sources familiar with the matter. The move aims to shield EU production of another key chemical in the value chain from unfairly priced Chinese imports

Saipem/Subsea7: Parties Could Offer Divestitures to Secure Approval, Sources Say

Saipem (SPM) and Subsea7 (SUBC) are considering offering divestitures in Northern Europe, if necessary, to secure phase 1 approval from the European Commission for their $4.6 billion merger,...

Jun 03, 2026 Read Now >

Tech/Media/Telecom Weekly: Survival of Texas App Store Accountability Act Could Encourage Other States; FCC Poised to Lift Ownership Cap; Vietnam Trade Probe Could Trigger Increased Tariffs on Electronics; Student-athletes Left Out of Cruz-Cantwell NCAA Antitrust Discussion; Vermont Passes Privacy Measure, But Will Governor Sign?

The TMT Weekly is a forward-looking tipsheet that covers tech policy across The Capitol Forum’s U.S. policy coverage universe, from Congress to the Courts. If you have any feedback, feel free to...

Jun 02, 2026 Read Now >

The European Antitrust Agenda: Von der Leyen Urged to Greenlight Google Penalty; JD.com Stands Against FSR Probe

Welcome to The European Antitrust Agenda, brought to you by Europe Executive Editor Javier Espinoza and Senior Correspondents Lydia O’Neal, Barbara Pianese, Joanna Sopinska and Catherine Stupp....

Jun 02, 2026 Read Now >

EU to Open China Dumping Probe into Key Chemical Imports, Sources Say

RELATED ARTICLES | Editor’s picks

Saipem/Subsea7: Parties Could Offer Divestitures to Secure Approval, Sources Say

The European Antitrust Agenda: Von der Leyen Urged to Greenlight Google Penalty; JD.com Stands Against FSR Probe

FILTER BY

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.